American Society of Hematology/LinkedIn
Sep 22, 2026, 07:39
Better Trials and Better Treatments Through Greater Inclusion – American Society of Hematology
American Society of Hematology shared a post on LinkedIn about a recent article by Alan Mast and Leonard A Valentino, published in JAMA Oncology, adding:
“Better representation can lead to better trials and better treatments.
Alan Mast, MD, PhD, and Leonard A. Valentino, MD, discuss why inclusion in clinical research matters, steps ASH is taking to address barriers to participation, and tools available to help build more representative clinical trials.”
Title: Better Trials, Better Treatments: Advancing Inclusion and Representation in Clinical Trials
Authors: Alan Mast and Leonard A. Valentino
Other posts featuring American Society of Hematology on Hemostasis Today.
Alan Mast
American Society of Hematology
ASH
Clinical Research
clinical research participation
clinical trials
diversity in clinical trials
health equity
Hematologic Malignancies
Hematology
Hemostasis News
Hemostasis Today
JAMA Oncology
Leonard A. Valentino
Medical Research
Oncology
patient inclusion
representation in research
-
Sep 22, 2026, 08:50Emily Horner: Lipoprotein(a) Links Oxidized Phospholipids to Platelet Hyperactivity
-
Sep 22, 2026, 08:42Sally Mandour: Bone Marrow Needle Gauge Explained
-
Sep 22, 2026, 08:39Alessandro Sionis: Navigating Anticoagulation in Mechanical Circulatory Support
-
Sep 22, 2026, 08:28Raghavendra Rao: The Latest Research on Varicose Veins
-
Sep 22, 2026, 08:23Aravind Palraj: Three Essential Tests in Antiphospholipid Syndrome
-
Sep 22, 2026, 08:18Salih Ehsan: Understanding the Major Glycoproteins on Platelets
-
Sep 22, 2026, 08:06Tim Brümmendorf: Exciting Sessions Ahead at ESHBMFS2026
-
Sep 22, 2026, 08:05Samin Mohsenian: Can Factor VII Activity Predict Bleeding Severity?
-
Sep 22, 2026, 07:59Cesar de Almeida Neto: Jehovah’s Witnesses Update Their Position on Blood Components